Harvard Medical School: Gene Vaccine
May 06, 2020
May 06, 2020
BOSTON, Massachusetts, May 6 -- Harvard Medical School issued the following news:
Harvard Medical School researchers based at Massachusetts Eye and Ear and Massachusetts General Hospital are announcing progress towards the testing and development of an experimental vaccine called AAVCOVID--a novel gene-based vaccine candidate against SARS-CoV-2, the virus that causes COVID-19.
The AAVCOVID vaccine program is a gene-based vaccine strategy based on an adeno-associated vir . . .
Harvard Medical School researchers based at Massachusetts Eye and Ear and Massachusetts General Hospital are announcing progress towards the testing and development of an experimental vaccine called AAVCOVID--a novel gene-based vaccine candidate against SARS-CoV-2, the virus that causes COVID-19.
The AAVCOVID vaccine program is a gene-based vaccine strategy based on an adeno-associated vir . . .